stocktools
Dilution profile // every instrument, one screen, from SEC filings

Voyager Therapeutics, Inc. (VYGR)

CIK 1640266 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$400M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
MEDIUM+40% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
MEDIUM~10.5 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-11-042026-07-30

Latest: 61.6M shares as of Jul 30, 2026 (10-Q).

Cash runway

~11 months of cash left

burning $33.1M / quarter

Full breakdown: cash runway tool · source filing →

Warrants

Balance-sheet fair value of warrants: $6.3M as of Dec 31, 2014.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 6, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $400.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3Nov 10, 2025$400.0M registeredfiling →

Last 12 months: 0 executed · 1 registered.

UPDATEDec 1, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEDec 1, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDNov 10, 2025S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDJan 8, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDJan 4, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDJan 2, 2024Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDJan 9, 2023Unregistered share sale disclosed (8-K item 3.02)8-K →
UPDATENov 15, 2022Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVENov 15, 2022SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDNov 8, 2022S-3 registration — capacity to sell shares, not a sale yetS-3 →
UPDATEDec 3, 2019Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEDec 2, 2019SEC declared a registration effective — selling can beginEFFECT →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full VYGR workspace